auris medical stock split

The company is implementing a 1-for-20 reverse stock split of its common shares following board approval. Further information about the reverse stock split is provided in the Companys form 6-K which is filed.

Fda Crowns Johnson Johnson S Monarch Surgical Robot With Urology Nod

When did Auris Medicals stock split.

. Hamilton Bermuda April 30 2019 GLOBE NEWSWIRE -- Auris Medical Holding Ltd. Press release content from Globe Newswire. Auris Medical Holding Ltd.

The stock has a 52-week high of 228 and a 52-week low of 65 cents. The 1-20 reverse split was announced on Tuesday. The AP news staff was not involved in its creation.

Stock Ideas All-In-One Screener SP 500 Map SP 500 Bubble SP 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week3Y5Y. EARS a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in. At the end of April Auris Medical Holding NASDAQ.

Further information about the reverse stock split is provided in the Companys form 6-K which is filed today with the Securities and Exchange Commission. Is a clinical-stage biopharmaceutical company focused on the development of products that. Auris Medical stocks price quote with latest real-time prices charts financials latest news technical analysis and opinions.

The company is implementing a 1-for-20 reverse stock split of its common shares following board approval. Auris Medical shares reverse split on the morning of Wednesday. Through its subsidiaries Co.

The company is implementing a 1-for-20 reverse stock split of its common. Stock splits for stock EARS Auris Medical Holding Ltd. The reverse stock split is expected to become effective on May 1 2019 and the shares to begin trading on the split-adjusted basis on the Nasdaq Capital Market under the.

Auris Medical Holding is a holding company. A measure of how much a stock or. Auris Medical Stock vs.

Auris Medical Holding Ltd. Auris Medical shares reverse split before market open on Wednesday May 1st 2019. Oct 100 140 Dec 2019 50 100 Share Price Consensus Price Target.

Further information about the reverse stock split is provided in the Companys form 6-K which is filed. EARS said that it was performing a 1-for-20 reverse split of its stock effective at the start of this month. EARS a clinical-stage company dedicated to developing therapeutics that.

Sec Filing Procept Biorobotics Corp